Browsing by Author Alroughani, Raed

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2016Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched studyBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Kister, Ilya; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical NeurosciencesDiscontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched study, Journal of Neurology, Neurosurgery and Psychiatry, vol.87, 10, 2016,pp 1133-1137
2016Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched studyBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Kister, Ilya; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical NeurosciencesDiscontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched study, Journal of Neurology, Neurosurgery and Psychiatry, vol.87, 10, 2016,pp 1133-1137
2014Fingolimod after natalizumab and the risk of short-term relapseBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Girard, Marc; Hodgkinson, S.; Izquierdo, Guillermo; Jokubaitis, Vilija; Kalincik, Tomas; Lechner-Scott, Jeanette; Li, Vivien; Lugaresi, Alessandra; Central Clinical School: Inst. of Clinical NeurosciencesFingolimod after natalizumab and the risk of short-term relapse, Neurology, vol.82, 14, 2014,pp 1204-1211
2015Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosisBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Girard, Marc; Grammond, P; Horakova, Dana; Izquierdo, Guillermo; Jokubaitis, Vilija; Kalincik, Tomas; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Pucci, Eugenio; Rozsa, Csilla; Spelman, Timothy; Trojano, Maria; Central Clinical School: Inst. of Clinical NeurosciencesSwitch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis, Annals of Neurology, vol.77, 3, 2015,pp 425-435